Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Power List / 2021 / Biopharmaceuticals / Kiran Mazumdar Shaw

Kiran Mazumdar-Shaw

Executive Chairperson at Biocon and Biocon Biologics

  • Profile

Meet Kiran Mazumdar-Shaw

Mazumdar-Shaw is seen as a pioneering biotech entrepreneur, a healthcare visionary, a global influencer, and a philanthropist. She is the recipient of two of India's highest civilian honours: the Padma Shri and Padma Bhushan. She has also received many other accolades from overseas. She serves on the board of MIT, Pure-Tech Health, Infosys, and Narayana Health, and holds key positions in various industry, educational, government, and professional bodies globally.

“A positive outcome of the pandemic is the global commitment to collective surveillance and pandemic prevention and preparedness. At long last, healthcare investment is likely to see a sharp increase across the world. Moreover, the crisis has brought to the fore a host of complex issues around drug pricing and distribution, as well as a number of social and other inequalities that are now demanding close attention.”

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.